Cerevast Medical Enters Into Strategic Collaboration With Lantheus Medical Imaging for Retinal Vein Occlusion Treatment

Under a development and commercial supply agreement, Lantheus’ microbubble will be used in combination with Cerevast’s ocular ultrasound device to target improving blood flow in occluded retinal veins in the eye.

CLOTBUST-ER Results Published in Lancet Neurology

The results of the CLOTBUST-ER trial, the first phase 3 trial to assess the safety and efficacy of sonothrombolysis, have been published in the April 2019 edition of Lancet Neurology.

New Approach

Baptist Hospital chosen as initial site for study that may have global implications, impact future of treating stroke patients

Cerevast Licenses Ultrasound Neuromodulation Technologies from Arizona State University for Post-Stroke Rehabilitation

Cerevast Medical, Inc., a medical technology company that develops medical products for the treatment of neurologic disorders, has licensed several technologies from Arizona State University to be used in innovative post-stroke rehabilitation devices.